[c09aa8]: / clusters / 9knumclustersv2 / clust_2301.txt

Download this file

78 lines (77 with data), 7.8 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
Ipsilateral diagnostic mammogram within months of enrollment
Ipsilateral breast had a previous cancer and/or prior in-field radiation
Unilateral DCIS: contralateral normal mammogram ? months of registration and ipsilateral breast imaging ? days of registration (must include ipsilateral mammogram; can also include ultrasound or breast MRI)
Any previous history of ipsilateral invasive breast cancer or ipsilateral DCIS; (patients with synchronous or previous ipsilateral LCIS are eligible)
Any prior history, not including the index cancer, of ipsilateral invasive breast cancer or ipsilateral DCIS treated with radiation therapy; (patients with synchronous or previous ipsilateral LCIS are eligible)
Any history, not including the index cancer, of ipsilateral or contralateral invasive breast cancer or ipsilateral or contralateral DCIS treated with radiation therapy (RT)\r\n* Note: Patients with synchronous or previous ipsilateral LCIS are eligible
History of ipsilateral or contralateral breast or thoracic RT for any condition
History of ipsilateral or contralateral axillary surgery for any condition
Recurrent ipsilateral breast cancer
Open surgery in ipsilateral breast within year.
Radiation therapy to ipsilateral breast [Period ]
Previous history of ipsilateral invasive breast cancer or ipsilateral DCIS. (Patients with synchronous or previous ipsilateral LCIS are eligible.)
No prior radiation to the ipsilateral breast
History of ipsilateral breast cancer treated with radiation therapy
Redo ipsilateral thoracotomy
No prior radiation to the ipsilateral breast, a history of contralateral breast radiation is permitted
History of ipsilateral cosmetic or reconstructive breast surgery
Prior history of breast cancer or in-field radiation in the ipsilateral breast
Prior or concurrent ipsilateral radiation therapy for invasive or noninvasive BC.
Patients for whom radiotherapy for breast cancer is contraindicated because of medical reasons (e.g., connective tissue disorder or prior ipsilateral breast radiation)
Breast imaging performed prior to study registration as follows:\r\n* Ipsilateral breast within weeks\r\n* Contralateral breast within weeks
History of ipsilateral invasive breast cancer or ipsilateral ductal carcinoma in situ (DCIS); Note: patients with history of ipsilateral lobular carcinoma in situ (LCIS) are eligible
Previous breast radiation on ipsilateral side or thoracic radiation on the ipsilateral side
No prior history of lung resection on ipsilateral side
Suspicious microcalcification, densities, or palpable abnormalities (in the ipsilateral or contralateral breast) unless biopsied and found to be benign
Patients with a history of prior breast cancer in the ipsilateral breast treated with lumpectomy alone (no RT) are eligible as long as the other entry criteria for this study are met
Suspicious microcalcifications, densities, or palpable abnormalities (in the ipsilateral or contralateral breast) unless these were biopsied and found to be benign
Prior ipsilateral breast or thoracic radiation for any condition
Previous history of ipsilateral invasive breast cancer or DCIS.
Any previously treated breast carcinoma or synchronous breast carcinoma in ipsilateral breast.
Suspicious microcalcifications, or densities (in the ipsilateral or contralateral breast as documented on mammogram or breast ultrasound) unless biopsied and found to be benign
No history of irradiation of the ipsilateral breast
No evidence of other areas worrisome for cancer on physical examination and mammography of the ipsilateral breast
A history of irradiation to the ipsilateral breast
Clinically detected or palpable disease prior to biopsy in either breast or ipsilateral axilla
Any previous history of ipsilateral invasive breast cancer or ipsilateral DCIS; (patients with synchronous or previous ipsilateral LCIS are eligible)
Patients must not have received any prior treatment of any kind to treat the current breast cancer including chemotherapy or endocrine therapy; in addition, any history of prior irradiation to the ipsilateral breast is excluded
Previous radiation therapy to the ipsilateral breast
Patients with a history of ipsilateral DCIS are eligible
Previous radiation therapy to the ipsilateral breast
Ipsilateral mammogram done greater than months prior to study
Patients must be a candidate for ipsilateral radiation therapy
History of ipsilateral breast cancer
Prior history of ipsilateral breast cancer
History of ipsilateral invasive breast cancer regardless of treatment or ipsilateral ductal carcinoma in situ (DCIS) treated with radiotherapy or contralateral invasive breast cancer at any time.
Prior history of radiation therapy to the ipsilateral breast and/or regional nodes is not allowed (prior RT to other sites is permitted).
Patients with ipsilateral treatment for DCIS or breast cancer within months prior to entering this study
Previous breast radiation on either side or thoracic radiation on the ipsilateral side
Histological or cytological diagnosis of ES-SCLC (Note: Extensive-stage disease is defined as disease beyond the ipsilateral hemithorax, mediastinum and ipsilateral supraclavicular area and including malignant pleural or pericardial effusion or hematogenous metastases)
Patients with only one kidney that is ipsilateral to the mesothelioma
Recurrent ipsilateral breast cancer
Open surgery in the ipsilateral breast within year of AVB- administration
History of radiation therapy to ipsilateral breast
Prior resection of jugular nodes ipsilateral to tumor
Any prior history, not including the index cancer, of ipsilateral invasive breast cancer or ipsilateral ductal breast carcinoma in situ (DCIS) treated with radiation therapy; (Patients with synchronous or previous ipsilateral lobular breast carcinoma in situ [LCIS] are eligible)
Prior ipsilateral breast cancer radiotherapy will be excluded; prior contralateral breast cancer therapy within years will also be excluded
Previous radiation therapy to the ipsilateral breast
Previous radiation to the ipsilateral breast
History of prior ipsilateral lung interventions including:\r\n* Chest tube placement\r\n* Surgery\r\n* Pleurodesis\r\n* Radiation treatment
Normal ipsilateral fibula without planned fibular osteotomy at time of surgery
Prior radiation therapy to the breast or ipsilateral regional nodes not allowed (a history of radiation therapy to other sites is permissible)
Subject has a history of recurrent breast cancer in the ipsilateral breast
Prior history of ipsilateral breast cancer (DCIS, LCIS [lobular cancer in situ] or invasive)
Patients with synchronous ipsilateral invasive breast cancer or any prior history of ipsilateral invasive breast cancer; (patients with previous ipsilateral/contralateral DCIS or previous contralateral invasive breast cancer treated with anti-cancer therapy are eligible)
Patients with a prior history of ipsilateral breast cancer
Participants with prior history of ipsilateral breast carcinoma treated with BCS and radiation therapy
Participants with prior history of ipsilateral breast carcinoma
Prior history of breast cancer in the ipsilateral breast
Patients must not have previous ipsilateral invasive breast cancer or DCIS
Have a recurrence of ipsilateral breast cancer
Ipsilateral biopsy-proven invasive breast cancer < cm in maximal dimension by ultrasound or mammography
Prior history of ipsilateral breast cancer
Prior ipsilateral breast cancer surgeries, mastectomies, breast reconstructions or implants.
Prior ipsilateral reduction mammoplasties (breast reductions) performed less than years prior to enrollment to this study.
Prior breast malignancy of the ipsilateral breast.
Patients with prior ipsilateral thoracic or breast radiation
Patients with recurrent ipsilateral DCIS